| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXSL2000212 | 人轮状病毒减毒活疫苗 | Diagnostic reagent | Biological Products(3.1) | Import Drug Application | 2020-12-03 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | In Review | 2020-12-03 | view | |
| JTS2400039 | 人轮状病毒减毒活疫苗标准品 | Other | Biological Products | Disposable Import Drug Application | 2024-05-22 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | view | ||||
| JTS2400038 | 人轮状病毒减毒活疫苗标准品 | Other | Biological Products | Disposable Import Drug Application | 2024-04-29 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | view | ||||
| JXSL2200131 | 人轮状病毒减毒活疫苗 | Diagnostic reagent | Biological Products(3.1) | Import Drug Application | 2022-07-29 | GlaxoSmithKline Biologicals SA | view | ||||
| JXSB2200005 | 人轮状病毒减毒活疫苗 | Diagnostic reagent | Biological Products(3.1) | Supplementary Application | 2022-01-10 | GlaxoSmithKline Biologicals SA | view |